3M Completes Spin-off of Solventum

Go back to 3M Completes Spin-off of Solventum

3M (MMM) PT Lowered to $78 at RBC Capital

April 2, 2024 7:17 AM EDT

RBC Capital analyst Deane Dray lowered the price target on 3M (NYSE: MMM) to $78.00 (from $84.00) while maintaining a Underperform rating.

The analyst comments "In this report, we are updating our model and price target for Underperform-rated 3M following the Apr-1 spinoff of... More

3M (MMM) PT Lowered to $100 at BofA Securities

April 2, 2024 5:24 AM EDT

BofA Securities analyst Andrew Obin lowered the price target on 3M (NYSE: MMM) to $100.00 (from $110.00) while maintaining a Neutral rating.

The analyst comments "On 4/1 it was announced that 3M had received final approval for its settlement with Public Water Suppliers (PWS). The... More

3M (MMM) PT Lowered to $100 at CFRA

April 1, 2024 4:58 PM EDT

CFRA analyst Jonathan Sakraida lowered the price target on 3M (NYSE: MMM) to $100.00 (from $110.00) while maintaining a Hold rating.

The analyst comments "MMM shares are settling lower today following the spin-off of Solventum (SOLV), MMM's healthcare business. Holders of MMM stock... More